Teck Resources Ltd. Cl B Stock Falls Wednesday, Underperforms Market
Dow Jones2026/10/07 20:35This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Teck Resources Ltd. Cl B TECK.B shed 2.22% to C$93.26 Wednesday, in what proved to be an all-around negative trading session for the Canadian market, with the S&P/TSX Composite Index falling 1.70% to 35,041.86. Teck Resources Ltd. Cl B closed 6.7% short of its 52-week high of C$99.91, which the company reached on September 8th. Trading volume of 966,528 shares remained below its 50-day average volume of 1.2 M. Data source: Dow Jones Market Data, FactSet. Data compiled October 7, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires October 07, 2026 16:35 ET (20:35 GMT)
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Teck Resources Ltd. Cl B TECK.B shed 2.22% to C$93.26 Wednesday, in what proved to be an all-around negative trading session for the Canadian market, with the S&P/TSX Composite Index falling 1.70% to 35,041.86.
Teck Resources Ltd. Cl B closed 6.7% short of its 52-week high of C$99.91, which the company reached on September 8th.
Trading volume of 966,528 shares remained below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 7, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 07, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

No scientific evidence but viral on social media: “Bodybuilding miracle drug” peptide products deregulation file sent to the White House for review, Hims&Hers (HIMS.US) surged 6% in one day.
The temporary admission policy for peptides has been submitted to the White House for review, and compounding pharmacies are expected to receive approval to produce BPC-157 and other substances; HIMS closed up 6% on Thursday.
AiCoin丨10.16 Snapshot: PPI Exceeds Expectations, Russia Bans P2P, US Stock ETF Net Outflow
Yen barely gains on a BoJ push for hikes and a Tokyo stock rout
